Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure

Loris Pironi, Ezra Steiger, Francisca Joly, Geert J A Wanten, Cecile Chambrier, Umberto Aimasso, Anna Simona Sasdelli, Kinga Szczepanek, Amelia Jukes, Miriam Theilla, Marek Kunecki, Joanne Daniels, Mireille J Serlie, Sheldon C Cooper, Florian Poullenot, Henrik Højgaard Rasmussen, Charlene W Compher, Adriana Crivelli, Sarah-Jane Hughes, Lidia SantarpiaFrancesco William Guglielmi, Nada Rotovnik Kozjek, Lars Ellegard, Stéphane M Schneider, Przemysław Matras, Alastair Forbes, Nicola Wyer, Anna Zmarzly, Marina Taus, Margie O'Callaghan, Emma Osland, Ronan Thibault, Cristina Cuerda, Lynn Jones, Brooke Chapman, Peter Sahin, Núria M Virgili, Andre Dong Won Lee, Paolo Orlandoni, Konrad Matysiak, Simona Di Caro, Maryana Doitchinova-Simeonova, Luisa Masconale, Corrado Spaggiari, Carmen Garde, Aurora E Serralde-Zúñiga, Gabriel Olveira, Zeljko Krznaric, Estrella Petrina Jáuregui, Ana Zugasti Murillo, José P Suárez-Llanos, Elena Nardi, André Van Gossum, Simon Lal

Research output: Contribution to journalJournal articleResearchpeer-review

36 Citations (Scopus)
18 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science